Plain-English translation of NCT06248671 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Researchers want to confirm that atorvastatin, a medication commonly used for cholesterol, may also help prevent migraines. Small studies have suggested it works, so this larger trial will test whether taking atorvastatin daily reduces how often migraines occur in people who experience them regularly.
Current migraine prevention medications don't work well for everyone and can have uncomfortable side effects. This medication has shown promise in smaller studies, so researchers want to test it more thoroughly to see if it could offer people a new, potentially safer option for preventing migraines.
You likely qualify if…
You likely don't qualify if…
You will take a daily pill for 12 weeks — either the medication at a higher dose, the medication at a lower dose, or a placebo (dummy pill) that looks identical. You'll keep a headache diary to track your migraines throughout the study. The study is 'triple blind,' meaning you, your doctor, and the research team won't know which treatment you're receiving until the study ends, ensuring fair and unbiased results.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
Norway